Bergauer, Markus Ph.D.
Jones Day
222 East 41st Street
New York, NY 10017-6702
Phone: 1.212.326.3442 (Business Phone)
Fax: 1.212.755.7306 (Business Fax)
Contact Us (Business Email)
Websites associated with this firm:http://www.jonesday.comSummary
Current Employment Position(s)
IP Legal Intern
Languages
- German
- Italian
Lawyer Overview
Markus Bergauer drafts and prosecutes US and international patent applications and assists in patent due diligence and freedom-to-operate investigations in the pharmaceutical and biotechnology fields.
Markus previously worked as a deputy program leader of a full lead optimization program at GlaxoSmithKline's Psychiatry Center of Excellence for Drug Discovery in Verona, Italy. He is named co-inventor on several patent applications relating to psychiatry drug discovery. Markus obtained his Ph.D. in the area of organic and medicinal chemistry from the University of Erlangen-Nuremberg in Germany where he performed research within the Institute of Pharmacy on the synthesis of selective dopamine receptor ligands, protecting group development and solid phase synthesis. After obtaining his Ph.D. he received a scholarship from the German Academic Exchange Service (DAAD) and joined the Breslow Group at the chemistry department of Columbia University in New York City where he focused on the synthesis of small molecules and peptides as novel histone deacetylase inhibitors (HDACi).
Areas of Practice
- Intellectual Property
- Patent Prosecution
- Life Sciences
Representative Cases
- BIC develops global patent portfolio for razors, stationery devices, lighters and correction tape devices
- Cogentus establishes patent portfolio for antiplatelet agents and proton pump inhibitors
- Magnequench develops global patent portfolio for technology relating to rare-earth magnets
- MedImmune builds patent portfolio for genetically engineered negative strand RNA viruses , (2009)
- Osteologix develops global patent portfolio for technology used in treating bone diseases
- Symphony Capital forms joint venture with OXiGENE
- Warren Pharmaceuticals establishes patent portfolio for cytoprotective cytokines, including erythropoietin
West Practice Categories
Copyrights, Intellectual Property Law, International Intellectual Property, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks
Qualifications
Education
- Friedrich-Alex Erlangen-Nurn
Office Information
Address
222 East 41st Street
New York, NY 10017-6702
Phones
1.212.326.3442 (Business Phone)
Faxes
1.212.755.7306 (Business Fax)
Emails
Contact Us (Business Email)
